Literature DB >> 14221728

A STUDY OF STRUCTURE--ACTIVITY RELATIONSHIPS IN REGARD TO SPECIES DIFFERENCE IN THE PHENYLBUTAZONE SERIES.

J M PEREL, M M SNELL, W CHEN, P G DAYTON.   

Abstract

Entities:  

Keywords:  ANALGESICS AND ANTIPYRETICS; CHEMISTRY; DOGS; EXPERIMENTAL LAB STUDY; GLUCURONATES; METABOLISM; OXYPHENBUTAZONE; PHENYLBUTAZONE; SPECIES SPECIFICITY

Mesh:

Substances:

Year:  1964        PMID: 14221728     DOI: 10.1016/0006-2952(64)90231-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  12 in total

1.  Disposition and oxidative metabolism of phenylbutazone in man.

Authors:  J Aarbakke; O M Bakke; E J Milde; D S Davies
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

2.  Increased oxidation of phenylbutazone during hydrocortisone infusion in man.

Authors:  J Aarbakke; M R Bending; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

3.  The effect of L-tryptophan administration on the concentration of probenecid in plasma and cerebrospinal fluid in patients.

Authors:  D L Dunner; S Heiber; J M Perel
Journal:  Psychopharmacology (Berl)       Date:  1977-08-16       Impact factor: 4.530

Review 4.  Clinical pharmacokinetics and potentially important drug interactions of sulphinpyrazone.

Authors:  A K Pedersen; P Jakobsen; J P Kampmann; J M Hansen
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

5.  Pharmacokinetics of phenylbutazone and oxyphenabutazone in the pig.

Authors:  E F Hvidberg; F Rasmussen
Journal:  Can J Comp Med       Date:  1975-01

6.  Mass spectrometric and tandem mass spectrometric behavior of nitrocatechol glucuronides: a comparison of atmospheric pressure chemical ionization and electrospray ionization.

Authors:  H Keski-Hynnilä; L Luukkanen; J Taskinen; R Kostiainen
Journal:  J Am Soc Mass Spectrom       Date:  1999-06       Impact factor: 3.109

7.  Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials.

Authors:  Ben Gold; Maneesh Pingle; Steven J Brickner; Nilesh Shah; Julia Roberts; Mark Rundell; W Clay Bracken; Thulasi Warrier; Selin Somersan; Aditya Venugopal; Crystal Darby; Xiuju Jiang; J David Warren; Joseph Fernandez; Ouathek Ouerfelli; Eric L Nuermberger; Amy Cunningham-Bussel; Poonam Rath; Tamutenda Chidawanyika; Haiteng Deng; Ronald Realubit; J Fraser Glickman; Carl F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-10       Impact factor: 11.205

8.  Pharmacokinetics of methylphenidate in hyperkinetic children.

Authors:  B L Hungund; J M Perel; M J Hurwic; J Sverd; B G Winsberg
Journal:  Br J Clin Pharmacol       Date:  1979-12       Impact factor: 4.335

Review 9.  Clinical pharmacokinetics of phenylbutazone.

Authors:  J Aarbakke
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

Review 10.  Sulfinpyrazone: a review of its pharmacological properties and therapeutic use.

Authors:  E H Margulies; A M White; S Sherry
Journal:  Drugs       Date:  1980-09       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.